Showing 1‐10 of 128
Cell & Gene
26 Sep 2024
Lonza Walkersville Commences Expansion of Endotoxin Assay Production Facility
Lonza Walkersville is investing in an expansion of its endotoxin assay production facility The upgraded facility will incorporate sustainable technologies and streamline...
Cell & Gene
24 Sep 2024
Lonza and Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY® (exagamglogene autotemcel)
Lonza to manufacture CASGEVY®, the world’s first CRISPR/Cas9 gene-edited cell therapy, for global commercial supply CASGEVY® will be manufactured at Lonza’s Geleen (NL) cell...
Cell & Gene
13 Aug 2024
Champalimaud Foundation Adopts Lonza’s MODA-ES® Platform to Streamline Cell Therapy Manufacturing
MODA-ES® Platform, a next-generation manufacturing execution system for cell and gene therapies, facilitates a cost-effective transition to electronic record-keeping By...
Cell & Gene
09 Apr 2024
NeuroSense Collaborates with Lonza to Identify Exosome-based Biomarkers, in order to Advance Neurodegenerative Disease Treatments and Diagnostics
NeuroSense will leverage its extensive experience in biomarker utilization to advance early diagnosis and treatment in the neurodegeneration field Lonza to develop, optimize,...
Cell & Gene
24 Oct 2023
Lonza’s Rapid PyroCell® Monocyte Activation Test Systems Make Rabbit-Free Pyrogen Testing Faster, Easier, and More Efficient
Lonza launched PyroCell® MAT Rapid System and PyroCell® MAT Human Serum (HS) Rapid System, two sustainable monocyte activation test (MAT) systems containing the new PeliKine...
Cell & Gene
07 Sep 2023
Lonza Upgrades MODA-ES® Module for Enhanced Electronic Batch Record Execution
The MODA-ES® Module v4.0 is an electronic batch record solution that helps pharmaceutical customers to expedite batch release by minimizing paper-based processes The improved...
Cell & Gene
30 Aug 2023
Lonza and Vertex Celebrate Groundbreaking of Cell Therapy Manufacturing Facility in Portsmouth (US)
The large-scale facility will support the development and commercialization of the Vertex type 1 diabetes (T1D) cell therapy portfolio At the facility’s groundbreaking event...
Cell & Gene
08 Aug 2023
Lonza Launches Nebula® Absorbance Reader for Streamlined Endotoxin and Pyrogen Testing
Lonza adds new Nebula® Absorbance Reader to its portfolio of Lonza-developed and optimized microplate readers for streamlined endotoxin and pyrogen testing The instrument is...
Cell & Gene
17 Jul 2023
Lonza Launches TheraPRO® CHO Media System to Improve Productivity and Quality in Therapeutic Protein Manufacture
Lonza’s new cell culture media system is designed to optimize the production of therapeutic monoclonal antibodies The two-part production system is proven to yield...
Cell & Gene
17 Jul 2023
Lonza Launches TheraPRO® CHO Media System to Improve Productivity and Quality in Therapeutic Protein Manufacture
Lonza’s new cell culture media system is designed to optimize the production of therapeutic monoclonal antibodies The two-part production system is proven to yield...
1 2 3 4 ... 13 >